Iqvia to redeem 3½% notes due 2024 with proceeds of new notes

By Rebecca Melvin

New York, June 9 – Iqvia Inc., a subsidiary of Iqvia Holdings Inc., plans to redeem its outstanding 3½% notes due 2024 (ISINs: XS1492821738 and XS1492822033) and repay a portion of borrowings under its revolving credit facility with the proceeds of new notes, according to a company news release on Tuesday.

The redemption price is 101.75% of par plus accrued interest, and the notes will be redeemed on July 9, conditional on the pricing of the new notes.

The subsidiary plans to price an $800 million equivalent of euro-denominated senior notes due 2028.

Questions may be directed to paying agent Elavon Financial Services DAC, U.K. Branch (agency.sercices.europe@usbank.com).

The provider of health information technologies and clinical research is based in Durham, N.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.